GPX4 and hepatocellular carcinoma: DHA downregulated the SLC7A11 expression and reduced the GSH and GPX4 levels along with increasing the cellular lipid ROS level in lung cancer cells, hepatocellular carcinoma cells, and head and neck carcinoma cells (Lin et al., 2016; Yuan et al., 2020; Su et al., 2021).